Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 2.00 | 117.50 | 0.0170 | -0.7261 | |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 2.00 | 117.50 | 0.0170 | -0.7261 | |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 115.00 | 117.50 | 0.9787 | 0.9791 | |
| BT-20 | 17-AAG | 3.1623 | uM | 7 | 156.25 | 28.40 | 66.00 | 117.50 | 0.5617 | 0.5093 |
| BT-20 | Erlotinib | 0.01 | uM | 7 | 156.25 | 28.40 | 141.00 | 117.50 | 1.2000 | 1.1861 |
| BT-20 | Linsitinib | 3.1623 | uM | 7 | 156.25 | 28.40 | 131.00 | 117.50 | 1.1149 | 1.1090 |
| BT-20 | Erlotinib | 0.0033113 | uM | 7 | 156.25 | 28.40 | 149.00 | 117.50 | 1.2681 | 1.2458 |
| BT-20 | Lapatinib | 10 | uM | 7 | 156.25 | 28.40 | 22.00 | 117.50 | 0.1872 | -0.1171 |
| BT-20 | Linsitinib | 0.0033113 | uM | 7 | 156.25 | 28.40 | 169.00 | 117.50 | 1.4383 | 1.3882 |
| BT-20 | Erlotinib | 3.1623 | uM | 7 | 156.25 | 28.40 | 151.00 | 117.50 | 1.2851 | 1.2605 |
| BT-20 | Lapatinib | 1 | uM | 7 | 156.25 | 28.40 | 143.00 | 117.50 | 1.2170 | 1.2012 |
| BT-20 | Lapatinib | 0.31623 | uM | 7 | 156.25 | 28.40 | 187.00 | 117.50 | 1.5915 | 1.5091 |
| BT-20 | Erlotinib | 10 | uM | 7 | 156.25 | 28.40 | 137.00 | 117.50 | 1.1660 | 1.1556 |
| BT-20 | Erlotinib | 19.9526 | uM | 7 | 156.25 | 28.40 | 152.00 | 117.50 | 1.2936 | 1.2678 |
| BT-20 | 17-AAG | 0.0016596 | uM | 7 | 156.25 | 28.40 | 147.00 | 117.50 | 1.2511 | 1.2310 |
| BT-20 | 17-AAG | 10 | uM | 7 | 156.25 | 28.40 | 57.00 | 117.50 | 0.4851 | 0.4051 |
| BT-20 | Linsitinib | 0.01 | uM | 7 | 156.25 | 28.40 | 117.00 | 117.50 | 0.9957 | 0.9958 |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 151.00 | 117.50 | 1.2851 | 1.2605 | |
| BT-20 | Linsitinib | 10 | uM | 7 | 156.25 | 28.40 | 96.00 | 117.50 | 0.8170 | 0.8122 |
| BT-20 | Linsitinib | 19.9526 | uM | 7 | 156.25 | 28.40 | 56.00 | 117.50 | 0.4766 | 0.3930 |
| BT-20 | Erlotinib | 0.31623 | uM | 7 | 156.25 | 28.40 | 145.00 | 117.50 | 1.2340 | 1.2162 |
| BT-20 | 17-AAG | 0.0033113 | uM | 7 | 156.25 | 28.40 | 95.00 | 117.50 | 0.8085 | 0.8029 |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 110.00 | 117.50 | 0.9362 | 0.9366 | |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 101.00 | 117.50 | 0.8596 | 0.8576 | |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 2.00 | 117.50 | 0.0170 | -0.7261 |